Every 8-K that VERADIGM INC (MDRX) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 8-K covers material events a company has to report between its quarterly reports, so if you follow MDRX and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full MDRX filings page.
Veradigm Inc. (MDRX) reports that a third-party vendor suffered a cybersecurity incident affecting data for a small number of Veradigm customers. An unauthorized party obtained vendor credentials to a Veradigm application programming interface and downloaded certain patients’ personal data, including some Social Security numbers, but no clinical or medical data.
The compromised credentials only allowed access through that limited interface and did not reach Veradigm’s broader network, servers, databases, or other systems, and there were no operational disruptions. Veradigm initiated its incident response protocols, notified law enforcement, and is notifying affected customers and individuals, offering credit monitoring where applicable. Potential liabilities are still being assessed, but Veradigm currently does not believe the incident is reasonably likely to have a material impact on its business, operations, financial condition, or results of operations.
Veradigm Inc. (MDRX) reported a scheduling change for its upcoming investor appearance at the 2026 Jefferies Healthcare Services and Technology Conference. The company’s fireside chat on September 15, 2026 in Nashville, Tennessee has been moved from 4:10 PM CT to 3:35 PM CT.
The change applies only to the Jefferies conference; previously announced details for Veradigm’s participation in the Deutsche Bank 2026 Healthcare Summit in New York, New York on September 16, 2026 remain the same. Veradigm stated that a live webcast of the Jefferies fireside chat will be available on its investor relations website.
Veradigm Inc. reported that its management team will participate in two investor conferences in September 2026, as a Regulation FD communication. At the 2026 Jefferies Healthcare Services and Technology Conference in Nashville on September 15, 2026, CEO Don Trigg and CFO Christian Greyenbuhl will hold one-on-one meetings and take part in a fireside chat at 4:10 PM CT, with a live webcast available on the company’s investor relations website. The same executives will also attend the Deutsche Bank 2026 Healthcare Summit in New York on September 16, 2026 for one-on-one meetings. Veradigm describes itself as a provider of clinical and revenue cycle solutions for independent practices, supporting over 20,000 provider practices with AI-focused data and technology.
Veradigm Inc. reported an update to its prior Stockholder Agreement with Charles Myers and Jessica Myers. The agreement, which provides Myers with observer rights on Veradigm’s board of directors, was previously amended in July 2025 and January 2026.
On June 25, 2026, Veradigm and the Myers Parties agreed to extend the term of this Agreement to December 31, 2026. Both sides indicated they do not anticipate any further extension beyond that date, signaling a defined end point for the current board observer arrangement.
Veradigm Inc. entered into a Consulting Agreement with former interim CFO Leland Westerfield and Wilcox Capital LLC, effective June 1, 2026. The contractor will act as a Strategic Financial Advisor through March 31, 2027, helping with the CFO transition, SEC reporting and addressing material weaknesses in internal controls.
The company will pay a consulting fee of $45,937.50 per month for ten months, with the final two payments contingent on Westerfield signing and not revoking a general release of claims. Veradigm will also grant restricted stock units valued at $100,000 after it files its 2023 and 2024 Form 10-Ks, with those units vesting on March 31, 2027.
Veradigm Inc. appointed Christian Greyenbuhl as its new Chief Financial Officer, principal financial officer and principal accounting officer, effective on the later of May 11, 2026 and the first business day after the company files its 2023 and 2024 Form 10-Ks, or as otherwise agreed. He replaces interim CFO Lee Westerfield, who is expected to move into a consulting role, and the company also plans the departure of Senior Vice President and General Counsel Tejal Vakharia.
Greyenbuhl’s compensation includes a $580,000 base salary, a $300,000 sign-on bonus, a target annual bonus equal to 75% of base salary, and an initial equity grant valued at $3,000,000 split between restricted stock units and performance stock units. Veradigm amended its 2024 Stock Incentive Plan to add 6,000,000 authorized shares, bringing the total available for equity awards to 17,000,000 shares.
Veradigm Inc. reported that the U.S. Securities and Exchange Commission’s Division of Enforcement has formally concluded its investigation into the company and, based on the information currently available, does not intend to recommend an enforcement action. This letter, issued under Securities Act Release No. 5310, marks the official end of the inquiry.
The company also noted that former Chief Executive Officer Richard J. Poulton and former Chief Financial Officer Leah S. Jones received similar letters from the SEC. The investigation stemmed from Veradigm’s voluntary disclosure of an independent Audit Committee review related to financial reporting and internal control matters described in a report filed on January 10, 2024.
Veradigm Inc. released preliminary, unaudited figures for 2024–2025 and a business update under its “Reset, Recover, Reignite” strategy. Management estimates GAAP revenue between $590–$595 million for the year ended December 31, 2024, and between $584–$589 million for 2025, which the company notes is about 1% lower at the mid-point versus 2024.
Cash and cash equivalents were $294 million at December 31, 2024 and $120 million at December 31, 2025, with a $174 million decrease driven mainly by $159 million net outflows from debt activities, including repayment of $229 million in Convertible Notes partly offset by $70 million of term-loan borrowings. Transaction and other expenses were $62 million, capital expenditures were $32 million, and debt was $75 million at year-end 2025 under a senior secured term loan maturing in 2030. The company reported 108.8 million common shares and 11.6 million unvested RSUs outstanding as of December 31, 2025.
Veradigm Inc. filed a current report describing another change to its stockholder rights plan. On February 2, 2026, the company and Broadridge Corporate Issuer Solutions, LLC signed Amendment No. 6 to the Stockholder Rights Agreement, extending the plan’s Final Expiration Time to the Close of Business on December 31, 2026.
The filing also recounts prior amendments, including an August 20, 2025 change that raised the “Specified Percentage” triggering threshold for certain stockholders from 10% to 20% and a February 20, 2025 amendment that reduced the Exercise Price for each one one-thousandth of a share of Series A Junior Participating Preferred Stock from $50.00 to $32.00.
Veradigm Inc. reported that it has further amended its Stockholder Agreement with Charles Myers and Jessica Myers. Myers currently serves as an observer to Veradigm’s board of directors. On January 15, 2026, the company signed a Second Amendment that extends the agreement’s Termination Date to July 26, 2026, reflecting the value the company believes Myers has contributed in this observer role.
The amendment also allows Veradigm and the Myers Parties, by mutual consent, to extend the Termination Date again to January 26, 2027. This filing focuses on governance and board‑level engagement rather than financial results.